Sullivan Timothy Eugene Insider Trading

Get the latest insider transactions of Sullivan Timothy Eugene. Sullivan Timothy Eugene is Chief Financial Officer in Apellis Pharmaceuticals, Inc. ($APLS). Discover the current value of Sullivan Timothy Eugene shares.

Address: C/O G1 THERAPEUTICS, INC. 79 T.W. ALEXANDER DRIVE RESEARCH TRIANGLE PARK 27709NC

Sullivan Timothy Eugene is Insider in these Companies

TickerCompany NameCurrent and Previous PositionsTotal SharesCurrent Value ($)
APLSApellis Pharmaceuticals, Inc.Chief Financial Officer34,261

Insider Trading Transactions of Sullivan Timothy Eugene

DateTickerCompanyOwnerRelationship Transaction Cost ($) Shares Transaction Value ($) Total Shares
Feb 11 2021APLSApellis Pharmaceuticals, ...Sullivan Timothy EugeneChief Financial Offic ...Sell47.7285840,94434,261
Feb 01 2021APLSApellis Pharmaceuticals, ...Sullivan Timothy EugeneChief Financial Offic ...Buy0.007,500031,369
Feb 01 2021APLSApellis Pharmaceuticals, ...Sullivan Timothy EugeneChief Financial Offic ...Buy0.003,750035,119
Feb 01 2021APLSApellis Pharmaceuticals, ...Sullivan Timothy EugeneChief Financial Offic ...Option Exercise44.9045,0002,020,50045,000
Feb 01 2021APLSApellis Pharmaceuticals, ...Sullivan Timothy EugeneChief Financial Offic ...Option Exercise44.9022,5001,010,25022,500
Feb 01 2021APLSApellis Pharmaceuticals, ...Sullivan Timothy EugeneChief Financial Offic ...Buy0.007,500031,369
Feb 01 2021APLSApellis Pharmaceuticals, ...Sullivan Timothy EugeneChief Financial Offic ...Buy0.003,750035,119
Feb 01 2021APLSApellis Pharmaceuticals, ...Sullivan Timothy EugeneChief Financial Offic ...Option Exercise44.9045,0002,020,50045,000
Feb 01 2021APLSApellis Pharmaceuticals, ...Sullivan Timothy EugeneChief Financial Offic ...Option Exercise44.9022,5001,010,25022,500
Sep 03 2019APLSApellis Pharmaceuticals, ...Sullivan Timothy EugeneChief Financial Offic ...Buy29.7111,699347,63011,699
Feb 12 2019APLSApellis Pharmaceuticals, ...Sullivan Timothy EugeneChief Financial Offic ...Option Exercise13.8595,0001,315,75095,000
Feb 21 2018APLSApellis Pharmaceuticals, ...Sullivan Timothy EugeneChief Financial Offic ...Option Exercise14.9525,000373,75025,000